Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DataMEDS AIMEDS -3.35% Quick Ratio is 0.03 as of Mar. 2026, which is 80% below its 10-year median of 0.15. The stock has 6 warning signs investors should review. Among 121 Medical Distribution companies, DataMEDS AI ranks worse than 98.35% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. DataMEDS AI's quick ratio for the quarter that ended in Mar. 2026 was 0.03.
DataMEDS AI has a quick ratio of 0.03. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for DataMEDS AI's Quick Ratio or its related term are showing as below:
MEDS'
s Quick Ratio Range Over the Past 10 Years
Min: 0.03 Med: 0.15 Max: 0.26
Current: 0.03
During the past 4 years, DataMEDS AI's highest Quick Ratio was 0.26. The lowest was 0.03. And the median was 0.15.
MEDS's Quick Ratio is ranked worse than 98.35% of 121
companies
in the Medical Distribution industry
Industry Median: 1.05
vs MEDS: 0.03
DataMEDS AI (NAS:MEDS) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
DataMEDS AI Quick Ratio Related Terms
DataMEDS AI Quick Ratio Historical Data
* Premium members only.
The historical data trend for DataMEDS AI's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, DataMEDS AI's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DataMEDS AI Quick Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, DataMEDS AI's Quick Ratio distribution charts can be found below:
* The bar in red indicates where DataMEDS AI's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
DataMEDS AI's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DataMEDS AI (MEDS) has a Quick Ratio of 0.03 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on DataMEDS AI and its competitors. This is 80% below median its historical median of 0.15. Over the past decade, DataMEDS AI's Quick Ratio has ranged from 0.03 to 0.26. According to the industry distribution chart, DataMEDS AI ranks #119 out of 121 companies in the Medical Distribution industry, placing it in the top 98.3%.
Is DataMEDS AI's Quick Ratio too high?
DataMEDS AI's current Quick Ratio of 0.03 is 80% below median its 10-year median of 0.15. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.26. The Medical Distribution industry median Quick Ratio is 1.05. DataMEDS AI's value of 0.03 is 97.1% below this industry median. Based on the distribution chart, DataMEDS AI ranks #119 out of 121 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers.
How does DataMEDS AI's Quick Ratio compare to HEWA and BLMH?
According to the Medical Distribution industry distribution chart, DataMEDS AI ranks #119 out of 121 companies for Quick Ratio. This places DataMEDS AI in the lower half of its industry. The industry median Quick Ratio is 1.05. DataMEDS AI's value of 0.03 is 97.1% below this benchmark. Historically, DataMEDS AI's own Quick Ratio has ranged from 0.03 to 0.26 over the past decade. While the company's 10-year median is 0.15 vs. the industry median of 1.05, DataMEDS AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Distribution company?
The median Quick Ratio among Medical Distribution companies is 1.05, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DataMEDS AI's current Quick Ratio of 0.03 is 97.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on DataMEDS AI and its competitors. For the Medical Distribution industry, the median Quick Ratio is 1.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DataMEDS AI's current Quick Ratio is 0.03, which is 80% below median its own 10-year median of 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DataMEDS AI stock overvalued right now?
DataMEDS AI (MEDS) has a current Quick Ratio of 0.03. The current Quick Ratio is 0.03, which is 80% below median its 10-year median of 0.15 and 97.1% below the Medical Distribution industry median of 1.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For DataMEDS AI (MEDS), the current Quick Ratio is 0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDS has been successfully added to your 
